Literature DB >> 12001051

Pulmonary manifestations of uncomplicated falciparum and vivax malaria: cough, small airways obstruction, impaired gas transfer, and increased pulmonary phagocytic activity.

Nicholas M Anstey1, Susan P Jacups, Timothy Cain, Travis Pearson, Patrick J Ziesing, Dale A Fisher, Bart J Currie, Paul J Marks, Graeme P Maguire.   

Abstract

Despite recognition of acute respiratory distress syndrome in both falciparum and vivax malaria, disease-related changes in pulmonary function have not been defined, and underlying mechanisms are not well understood. Respiratory symptoms, pulmonary function, pulmonary phagocytic cell activity, and longitudinal changes were examined in 26 adults with uncomplicated falciparum, vivax, and ovale malaria after treatment. Self-limiting cough occurred in both falciparum (36%) and vivax or ovale (53%) malaria. In infection with each malaria species, admission measures of airflow and gas transfer were lower than predicted, and mean lung (99m)technetium-sulfur-colloid uptake was significantly increased. Changes were most evident in falciparum malaria, with treatment resulting in initial worsening of airflow obstruction and gas transfer. Altered pulmonary function in malaria is common and includes airflow obstruction, impaired ventilation, impaired gas transfer, and increased pulmonary phagocytic activity, and its occurrence in both vivax and falciparum malaria suggests that there may be common underlying inflammatory mechanisms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12001051     DOI: 10.1086/339885

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  47 in total

1.  Featured Article: Immunomodulatory effect of hemozoin on pneumocyte apoptosis via CARD9 pathway, a possibly retarding pulmonary resolution.

Authors:  Sitang Maknitikul; Natthanej Luplertlop; Urai Chaisri; Yaowapa Maneerat; Sumate Ampawong
Journal:  Exp Biol Med (Maywood)       Date:  2018-02-05

Review 2.  Imaging Plasmodium immunobiology in the liver, brain, and lung.

Authors:  Ute Frevert; Adéla Nacer; Mynthia Cabrera; Alexandru Movila; Maike Leberl
Journal:  Parasitol Int       Date:  2013-09-27       Impact factor: 2.230

3.  Lung injury in uncomplicated and severe falciparum malaria: a longitudinal study in papua, Indonesia.

Authors:  Graeme P Maguire; Tjandra Handojo; Michael C F Pain; Enny Kenangalem; Ric N Price; Emiliana Tjitra; Nicholas M Anstey
Journal:  J Infect Dis       Date:  2005-11-01       Impact factor: 5.226

4.  Plasmodium vivax Induced Acute Respiratory Distress Syndrome - A Diagnostic and Therapeutic Dilemma in Preeclampsia.

Authors:  Richa Sharma; Amita Suneja; Anu Yadav; Kiran Guleria
Journal:  J Clin Diagn Res       Date:  2017-04-01

Review 5.  Respiratory Complications of Plasmodium vivax Malaria: Systematic Review and Meta-Analysis.

Authors:  Fernando Val; Kim Machado; Lisiane Barbosa; Jorge Luis Salinas; André Machado Siqueira; Maria Graças Costa Alecrim; Hernando Del Portillo; Quique Bassat; Wuelton Marcelo Monteiro; Marcus Vinícius Guimarães Lacerda
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

6.  Three cases of ARDS: An emerging complication of Plasmodium vivax malaria.

Authors:  Supriya Sarkar; Kaushik Saha; Chandra Sekhar Das
Journal:  Lung India       Date:  2010-07

7.  A comparative study of clinical profiles of vivax and falciparum malaria in children at a tertiary care centre in uttarakhand.

Authors:  Ragini Singh; Shruti Kumar; S K Rana; Brijesh Thakur; S P Singh
Journal:  J Clin Diagn Res       Date:  2013-09-18

Review 8.  Vivax malaria: neglected and not benign.

Authors:  Ric N Price; Emiliana Tjitra; Carlos A Guerra; Shunmay Yeung; Nicholas J White; Nicholas M Anstey
Journal:  Am J Trop Med Hyg       Date:  2007-12       Impact factor: 2.345

Review 9.  Antimicrobial Therapy in the Context of the Damage-Response Framework: the Prospect of Optimizing Therapy by Reducing Host Damage.

Authors:  Liise-Anne Pirofski; Arturo Casadevall
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

10.  Plasmodium vivax malaria: an unusual presentation.

Authors:  Prasad Kasliwal; Manimala S Rao; Rash Kujur
Journal:  Indian J Crit Care Med       Date:  2009 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.